Alembic Pharma Panelav unit clears Brazil GMP audit
11 Dec 2024 //
BUSINESS STD
Alembic Pharma gets tentative USFDA nod for Olopatadine drug
04 Dec 2024 //
BUSINESS STD
Alembic Gains Guinness World Record for Hypertension Awareness
25 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma Gujarat facility gets 5 observations from USFDA
25 Nov 2024 //
BUSINESS STD
Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
12 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules
11 Nov 2024 //
BUSINESS STD
Alembic Pharma Q2 FY25 PAT up 12% to Rs. 153 Cr
07 Nov 2024 //
INDPHARMAPOST
Alembic Pharma gets FDA nod for generic hypertension capsules
21 Oct 2024 //
ECONOMICTIMES
Alembic rises after oncology completes FDA with `zero` observations
09 Oct 2024 //
BUSINESS STD
Alembic Pharma announces Joining of PM`s Internship Scheme Early
07 Oct 2024 //
EXPRESSPHARMA
Alembic gains FDA approval for Lamotrigine Extended-Release Tablets
04 Oct 2024 //
EXPRESSPHARMA
Alembic Gains USFDA Approval For Lamotrigine Extended-Release
03 Oct 2024 //
EXPRESSPHARMA
Alembic`s Generics Alcaftadine Receives Approval in US
02 Oct 2024 //
FDA
Alembic`s Generics Lamotrigine Receives Approval in US
01 Oct 2024 //
FDA
Alembic Pharma gets USFDA nod for schizophrenia Drug
28 Sep 2024 //
ECOMONICTIMES
Alembic`s Generics Paliperidone Receives Approval in US
26 Sep 2024 //
FDA
Alembic Pharma gets USFDA nod for generic drug
26 Aug 2024 //
ECONOMICTIMES
Alembic gets USFDA nod for generic medication
13 Aug 2024 //
ECONOMICTIMES
Alembic Pharmaceuticals Ltd leads losers in `A` group
09 Aug 2024 //
BUSINESS STANDARD
Indian drugmaker Alembic Pharma posts Q1 profit rise on strong US sales
07 Aug 2024 //
REUTERS
Alembic`s Generics Acitretin Receives Approval in US
05 Aug 2024 //
FDA
Alembic Nelarabine injection gets FDA final approval
05 Aug 2024 //
ECONOMICSTIMES
Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US
01 Aug 2024 //
FDA
Alembic`s Generics Fluphenazine HCl Receives Approval in US
22 Jul 2024 //
FDA
Alembic Gets USFDA Tentative Approval For Selexipag Injection
14 Jul 2024 //
INDIANPHARMAPOST
Alembic`s Generic Bromfenac Sodium Receives Approval in US
08 Jul 2024 //
FDA
Alembic Pharma gets tentative nod from USFDA for Ivosidenib tablets
05 Jul 2024 //
ECONOMIC TIMES
Alembic`s Generic Doxycycline Receives Approval in US
27 Jun 2024 //
FDA
Alembic Pharma gets USFDA final approval for Dabigatran Etexilate capsules
19 Jun 2024 //
INDIANPHARMAPOST
Alembic Pharma Gets USFDA Nod for Generic Hereditary Angioedema Injection
17 Jun 2024 //
ECONOMICTIMES
Alembic`s Generic Dabigatran Etexilate Mesylate Receives Approval in US
14 Jun 2024 //
FDA
Alembic`s Generic Icatibant Acetate Receives Approval in US
14 Jun 2024 //
FDA
Alembic`s Generic Clindamycin Phosphate Receives Approval the U.S.
03 Jun 2024 //
FDA
Alembic receives USFDA final approval for Sacubitril and Valsartan Tablets
29 May 2024 //
INDINPHARMAPOST
Alembic Pharma plans to launch 25 drugs in US generics segment this fiscal
16 May 2024 //
ECONOMICTIMES
Alembic Pharma net profit up by 16% in Q4, dividend at 550%
13 May 2024 //
PHARMABIZ
Alembic Pharmaceuticals posts Q4 FY24 PAT at Rs. 178.21 Cr
09 May 2024 //
INDINPHARMAPOST
Alembic Pharmaceuticals receives EIR from USFDA for oncoformulation facility
06 May 2024 //
INDINPHARMAPOST
Alembic`s Generic Clindamycin Phosphate Receives Approval in the U.S.
02 Apr 2024 //
FDA
Alembic Pharmaceuticals appoints Manish Kejriwal as Independent Director
02 Apr 2024 //
INDIANPHARMAPOST
Alembic Pharma gets tentative USFDA nod for breast cancer drug
02 Apr 2024 //
ECONOMICTIMES
USFDA conducts inspection at Alembic Pharmaceuticals` Panelav oncology formulation facility
09 Mar 2024 //
INDIANPHARMAPOST
Alembic`s Generic Bromfenac Receives Approval in the U.S.
07 Nov 2023 //
FDA
Alembic`s Generic Fluorouracil Receives Approval in the U.S.
18 Oct 2023 //
FDA
Manufacturing operations disrupted at Sikkim plant due to flash floods: Alembic
04 Oct 2023 //
ECONOMIC TIMES
Enforcement Report - Week of August 23, 2023
23 Aug 2023 //
FDA
Alembic, Aurobindo Pharma issue separate US drug recalls
21 Aug 2023 //
FIERCE PHARMA
Alembic aims for US rebound with new launches
16 Aug 2023 //
ECONOMIC TIMES
Alembic`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
07 Aug 2023 //
FDA
Alembic`s Generic Brimonidine Tartrate Receives Approval in the U.S.
01 Aug 2023 //
FDA
Alembic`s Generic Chlorpromazine Hydrochloride Receives Approval in the U.S.
18 Jul 2023 //
FDA
Alembic`s Generic Carboprost Tromethamine Receives Approval in the U.S.
15 Jun 2023 //
FDA
Alembic`s Generic Doxercalciferol Receives Approval in the U.S.
15 Jun 2023 //
FDA
Alembic`s Generic Nadolol Receives Approval in the U.S.
02 Jun 2023 //
FDA
Alembic Q4 FY23 consolidated PAT up at Rs. 48.25 Cr
13 May 2023 //
INDIAN PHARMA POST
Alembic Pharma gets EIR from USFDA for its solid oral formulation facility
10 May 2023 //
EXPRESS PHARMA
Alembic`s Generic Brimonidine Tartrate Receives Approval in the U.S.
29 Mar 2023 //
FDA
Alembic Pharmaceuticals receives 2 observations for Gujarat facility from USFDA
24 Mar 2023 //
ECONOMIC TIMES
Alembic intros generic Aubagio
22 Mar 2023 //
DRUGSTORENEWS